Dr. Ouafaa Morjani | Hassan II University of Casablanca | Morocco
Dr. Ouafaa Morjani is a dedicated researcher in Molecular Biology, Genetics, and Bioinformatics, holding a Ph.D. from Hassan II University of Casablanca, Morocco. Affiliated with the Faculty of Sciences and Technics of Mohammedia, her work is rooted in the Laboratory of Virology, Oncology, Biosciences, Environment, and New Energies. Her research primarily focuses on thoracic oncology, particularly Non-Small Cell Lung Cancer (NSCLC), where she integrates molecular profiling, genetic variants, biomarkers, and advanced diagnostic technologies to improve early detection and precision medicine. Dr. Morjani has authored and co-authored multiple peer-reviewed publications addressing clinical, anatomical, and molecular dimensions of lung cancer. Her work includes exploring GWAS-derived genetic variants in NSCLC, investigating interleukin-based blood biomarkers, analyzing metastasis patterns, and assessing the impact of smoking on lung cancer mechanisms. She has also presented extensively at prestigious international conferences in Morocco, France, and Saudi Arabia, contributing to discussions on NGS applications, ROS1 rearrangement detection, and molecular pathology. Her scientific expertise is strengthened by advanced training in Next-Generation Sequencing (NGS) at renowned institutions in France, along with hands-on experience in sequencing platforms such as Ion Torrent and Illumina. She is proficient in NGS library preparation, nucleic acid extraction, and bioinformatics analysis involving FastQ, BAM, and SAM files. Her competencies extend to R programming, statistical analysis, and functional genomics. She has participated in major workshops, including the African BioGenome Project Fellowship, enhancing her mastery of genome assembly, annotation, and biodiversity genomics. Dr. Morjani has additional experience in molecular diagnostics, including RT-qPCR detection of foodborne viruses and breast cancer biomarker analysis through IHC and FISH. She is also actively involved in teaching, mentoring, quality assurance, COVID-19 testing, and regulatory compliance. A member of multiple national and international scientific societies, she is recognized for her adaptability, teamwork, communication skills, and strong commitment to advancing cancer genomics and molecular oncology.
Featured Publications
Morjani, O., Benkirane, N., Errihani, H., Elfahime, E. M., & Lakhiari, H. (2024). Molecular analysis of genetic mutations in non-small cell lung cancer in Morocco. Pan African Medical Journal, 47(1).
Morjani, O., Benlhachemi, S., Errihani, H., El Fahime, E., & Lakhiari, H. (n.d.). Epidemiological, clinical, anatomopathological and molecular profiles of lung cancer in patients at the oncology center of the Cheikh Zaid International University Hospital in Rabat. [Journal information incomplete].
Morjani, O., Yang, Y.-W., Lahlil, R., Lakhiari, H., & Alaoui, H. (2025). Hematological biomarkers for early detection of lung cancer: Evaluating the diagnostic potential of circulating interleukin levels. International Journal of Molecular Sciences, 26(22), 11014.
Morjani, O., Mounaji, N., Ghaouti, M., Errihani, H., El Fahime, E., & Lakhiari, H. (2024). Next generation sequencing and genomic mapping: Towards precision molecular diagnosis of lung cancer in Morocco. Pan African Medical Journal, 49, 75.
Morjani, O., Karimoune, M. A. S., Errihani, H., El Fahime, E. M., & Lakhiari, H. (2023). Comparative study of molecular techniques for detecting ROS1 rearrangement in non-small cell lung cancer: Implications for diagnostic precision. Journal of Molecular Diagnostics, 26(6), S5–S6.